GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $110.00

GE HealthCare Technologies (NASDAQ:GEHC – Free Report) had its target price raised by Argus from $85.00 to $110.00 in a report released on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other analysts have also issued reports on the stock. Needham & Company LLC restated a “buy” rating and set a $93.00 target price on shares of GE HealthCare Technologies in a research report on Monday, October 5th. Bank of America restated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Thursday, October 29th. Royal Bank Of Canada boosted their price objective on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a research report on Thursday, October 29th. BTIG Research lifted their target price on GE HealthCare Technologies from $75.00 to $83.00 and gave the stock a “buy” rating in a research report on Wednesday, October 28th. Finally, Oppenheimer reaffirmed an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $82.17.

Get Our Latest Stock Report on GEHC

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $83.02 on Wednesday. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. The stock has a market cap of $37.54 billion, a PE ratio of 17.51, a price-to-earnings-growth ratio of 2.06 and a beta of 0.65. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The company’s fifty day moving average price is $70.55 and its 200-day moving average price is $70.11.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The firm had revenue of $5.51 billion for the quarter, compared to analysts’ expectations of $5.35 billion. During the same quarter in the prior year, the company posted $1.07 earnings per share. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. On average, equities analysts expect that GE HealthCare Technologies will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, October 23rd. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio is 3.38%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. State Street Corp raised its stake in shares of GE HealthCare Technologies by 0.6% during the 3rd quarter. State Street Corp now owns 20,997,119 shares of the company’s stock worth $1,372,582,000 after buying an additional 135,553 shares during the period. Barrow Hanley Mewhinney & Strauss LLC increased its position in shares of GE HealthCare Technologies by 2.3% during the third quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,769,864 shares of the company’s stock worth $900,136,000 after purchasing an additional 314,050 shares in the last quarter. Boston Partners increased its position in shares of GE HealthCare Technologies by 20.1% during the third quarter. Boston Partners now owns 6,188,021 shares of the company’s stock worth $404,501,000 after purchasing an additional 1,034,674 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of GE HealthCare Technologies by 2.0% in the first quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock valued at $384,219,000 after purchasing an additional 105,995 shares during the last quarter. Finally, Van ECK Associates Corp lifted its position in GE HealthCare Technologies by 4.1% during the second quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock worth $286,933,000 after buying an additional 177,028 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

(Get Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Further Reading

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.